Karin Thevissen - Genetic Mutations

Author Information

Karin Thevissen is an esteemed researcher affiliated with the Centre of Microbial and Plant Genetics at KU Leuven, located in Leuven, Belgium. Her work primarily revolves around microbial and plant genetics, with a particular focus on antifungal peptides and their mechanisms of action.

Research Contributions

Karin Thevissen has made significant contributions to the field of genetics and microbiology. Her research spans a variety of topics including the mode of antifungal activity of plant defensins, immune response in COVID-19, and the development of biomedical materials for controlled drug release. Notably, her work on the antifungal properties of peptides and the immune profiles of COVID-19 patients has been highly influential. The diversity of her research, ranging from single-cell analysis to bioactive glass materials, underscores her multidisciplinary approach to scientific inquiry.

Aliases

K. Thevissen, K Thevissen, Karin Thevissen

Publication and Citation Metrics

Citation Count	9126
h-index	52
Paper Count	220

Publications:

Multiplex Analysis to Unravel the Mode of Antifungal Activity of the Plant Defensin HsAFP1 in Single Yeast Cells

DOI: 10.3390/ijms23031515

Year: 2022

Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity

DOI: 10.1038/s41467-021-24360-w

Year: 2021

Tuning the Surface Interactions between Single Cells and an OSTE+ Microwell Array for Enhanced Single Cell Manipulation.

DOI: 10.1021/acsami.0c19657

Year: 2021

Development of mesoporous bioactive glass‐containing macroporous titanium for controlled release of antimicrobial drugs

DOI: 10.1111/jace.18105

Year: 2021

Membrane-Interacting Antifungal Peptides

DOI: 10.3389/fcell.2021.649875

Year: 2021

The Ketogenic Diet Revisited: Beyond Ketones

DOI: 10.3389/fneur.2021.720073

Year: 2021

Integrated Microwell Array Technologies for Single Cell Analysis

DOI: 10.1007/978-981-10-8953-4_21

Year: 2021

High dimensional profiling identifies specific immune types along the recovery trajectories of critically ill COVID19 patients

DOI: 10.1007/s00018-021-03808-8

Year: 2021

Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial

DOI: 10.1007/s00134-021-06431-0

Year: 2021

Combining Miconazole and Domiphen Bromide Results in Excess of Reactive Oxygen Species and Killing of Biofilm Cells

DOI: 10.3389/fcell.2020.617214

Year: 2020

What is Genetic Evolution?

Can Genetic Mutations from UV Radiation Be Prevented?

Are there preventive measures for PAH exposure?

What is Prenatal Screening?

What Genetic Conditions Are Commonly Addressed in Occupational Therapy?

What Are the Consequences of Genetic Mutations?

What is Sickle Cell Trait?

What is UV Radiation?

How Do Missense Mutations Differ from Other Types of Mutations?

How Do Beneficial Mutations Spread in Populations?

Partnered Content Networks

Relevant Topics